399 results
8-K
EX-99.1
lwzgxk2hq6wytu 26e8
17 Apr 24
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
7:30am
8-K
EX-3.1
nt61s0h3f fdik
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.1
mh1l5c0m3o f040r
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-2.1
5ekrep
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-99.1
knval3r4xg0s53
31 Jan 24
Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives
8:00am
8-K
EX-1.1
trd oj5iws11yl
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
8-K
EX-99.1
bnaghygrd9rl
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
424B5
8r7ygsc69gx95b
9 Nov 23
Prospectus supplement for primary offering
4:11pm